Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction

EMBO J. 2019 Dec 2;38(23):e101982. doi: 10.15252/embj.2019101982. Epub 2019 Oct 21.

Abstract

Cellular senescence has been shown to contribute to skin ageing. However, the role of melanocytes in the process is understudied. Our data show that melanocytes are the only epidermal cell type to express the senescence marker p16INK4A during human skin ageing. Aged melanocytes also display additional markers of senescence such as reduced HMGB1 and dysfunctional telomeres, without detectable telomere shortening. Additionally, senescent melanocyte SASP induces telomere dysfunction in paracrine manner and limits proliferation of surrounding cells via activation of CXCR3-dependent mitochondrial ROS. Finally, senescent melanocytes impair basal keratinocyte proliferation and contribute to epidermal atrophy in vitro using 3D human epidermal equivalents. Crucially, clearance of senescent melanocytes using the senolytic drug ABT737 or treatment with mitochondria-targeted antioxidant MitoQ suppressed this effect. In conclusion, our study provides proof-of-concept evidence that senescent melanocytes affect keratinocyte function and act as drivers of human skin ageing.

Keywords: SASP; melanocytes; senescence; skin ageing; telomeres.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / drug effects
  • Aging / pathology*
  • Atrophy / chemically induced
  • Atrophy / pathology*
  • Cells, Cultured
  • Cellular Senescence*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Epidermis / drug effects
  • Epidermis / pathology
  • Female
  • Humans
  • Male
  • Melanocytes / metabolism
  • Melanocytes / pathology*
  • Middle Aged
  • Paracrine Communication
  • Reactive Oxygen Species / metabolism
  • Receptors, CXCR4 / metabolism
  • Skin / metabolism
  • Skin / pathology*
  • Telomere / metabolism
  • Telomere / pathology*
  • Young Adult

Substances

  • CDKN2A protein, human
  • CXCR4 protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • Reactive Oxygen Species
  • Receptors, CXCR4